Keeley Asset Management’s Pfizer PFE Stock Holding History

Keeley Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.9M	Sell	94,146 -2,432	-3%	-$74.2K	0.12%	117
2016 Q3	$3.1M	Sell	96,578 -9,454	-9%	-$316K	0.13%	103
2016 Q2	$3.54M	Sell	106,032 -4,111	-4%	-$131K	0.15%	104
2016 Q1	$3.1M	Buy	110,143 +28,196	+34%	+$805K	0.12%	116
2015 Q4	$2.51M	Sell	81,947 -51,653	-39%	-$1.62M	0.08%	134
2015 Q3	$3.98M	Sell	133,600 -2,424	-2%	-$77.7K	0.11%	131
2015 Q2	$4.33M	Buy	136,024 +32,006	+31%	+$1.04M	0.1%	136
2015 Q1	$3.43M	Sell	104,018 -1,339	-1%	-$42.6K	0.07%	145
2014 Q4	$3.11M	Buy	105,357 +2,762	+3%	+$79.2K	0.06%	159
2014 Q3	$2.88M	Buy	102,595 +7,905	+8%	+$222K	0.06%	177
2014 Q2	$2.67M	Sell	94,690 -6,381	-6%	-$182K	0.05%	207
2014 Q1	$3.08M	Sell	101,071 -9,036	-8%	-$269K	0.05%	195
2013 Q4	$3.2M	Sell	110,107 -2,270	-2%	-$66.1K	0.05%	180
2013 Q3	$3.06M	Sell	112,377 -580	-0.5%	-$15.8K	0.06%	179
2013 Q2	$3M	Buy	+112,957	New	+$3.12M	0.06%	184

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Keeley Asset Management's PFE Position: Q4 2016 in Review

Keeley Asset Management reduced its Pfizer (PFE) stake by 2.5% in Q4 2016, selling an estimated $74.2K and leaving 94,146 shares worth $2.9M. The position accounts for 0.12% of the portfolio, ranked #117.

Keeley Asset Management first reported a position in PFE in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.33M in Q2 2015. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

Keeley Asset Management held 94,146 shares of Pfizer worth $2.9M as of Q4 2016.
Keeley Asset Management sold 2,432 Pfizer shares in Q4 2016, an estimated $74.2K.
Pfizer made up 0.12% of Keeley Asset Management's portfolio in Q4 2016, its #117 holding.
Keeley Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 15 quarters since.
Keeley Asset Management's Pfizer position peaked at $4.33M in Q2 2015.
2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on Keeley Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.